Mari A - Search Results

1

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes.

Polidori D, Mari A, Ferrannini E. Polidori D, et al. Among authors: mari a. Diabetologia. 2014 May;57(5):891-901. doi: 10.1007/s00125-014-3196-x. Epub 2014 Mar 1. Diabetologia. 2014. PMID: 24585202 Free PMC article. Clinical Trial.

2

Effect of acute hyperglycemia on insulin secretion in humans.

Toschi E, Camastra S, Sironi AM, Masoni A, Gastaldelli A, Mari A, Ferrannini E, Natali A. Toschi E, et al. Among authors: mari a. Diabetes. 2002 Feb;51 Suppl 1:S130-3. doi: 10.2337/diabetes.51.2007.s130. Diabetes. 2002. PMID: 11815471 Clinical Trial.

3

Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.

Mari A, Tura A, Gastaldelli A, Ferrannini E. Mari A, et al. Diabetes. 2002 Feb;51 Suppl 1:S221-6. doi: 10.2337/diabetes.51.2007.s221. Diabetes. 2002. PMID: 11815483

4

Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.

Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E. Mari A, et al. Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1159-66. doi: 10.1152/ajpendo.00093.2002. Epub 2002 Aug 6. Am J Physiol Endocrinol Metab. 2002. PMID: 12388151 Free article. Clinical Trial.

5

Visceral fat in hypertension: influence on insulin resistance and beta-cell function.

Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Buzzigoli E, Ghione S, Turchi S, Lombardi M, Ferrannini E. Sironi AM, et al. Among authors: mari a. Hypertension. 2004 Aug;44(2):127-33. doi: 10.1161/01.HYP.0000137982.10191.0a. Epub 2004 Jul 19. Hypertension. 2004. PMID: 15262911 Clinical Trial.

6

beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Ferrannini E, et al. Among authors: mari a. J Clin Endocrinol Metab. 2005 Jan;90(1):493-500. doi: 10.1210/jc.2004-1133. Epub 2004 Oct 13. J Clin Endocrinol Metab. 2005. PMID: 15483086

7

Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.

Mari A, Gastaldelli A, Natali A, Ostergard T, Schmitz O, Ferrannini E. Mari A, et al. Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E541-6. doi: 10.1152/ajpendo.00175.2004. Epub 2004 Nov 2. Am J Physiol Endocrinol Metab. 2005. PMID: 15522997 Free article.

8

beta-cell function in obesity: effects of weight loss.

Ferrannini E, Camastra S, Gastaldelli A, Maria Sironi A, Natali A, Muscelli E, Mingrone G, Mari A. Ferrannini E, et al. Among authors: mari a. Diabetes. 2004 Dec;53 Suppl 3:S26-33. doi: 10.2337/diabetes.53.suppl_3.s26. Diabetes. 2004. PMID: 15561918 Review.

9

Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.

Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E. Mari A, et al. Diabetes Care. 2005 May;28(5):1132-8. doi: 10.2337/diacare.28.5.1132. Diabetes Care. 2005. PMID: 15855578 Clinical Trial.

10

beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss.

Camastra S, Manco M, Mari A, Baldi S, Gastaldelli A, Greco AV, Mingrone G, Ferrannini E. Camastra S, et al. Among authors: mari a. Diabetes. 2005 Aug;54(8):2382-9. doi: 10.2337/diabetes.54.8.2382. Diabetes. 2005. PMID: 16046305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,182 results

Search Page

Filters